1
|
Yoshino R, Nakatsubo M, Ujiie N, Ito A, Yoshida N, Kitada M. Characteristics of Invasive Cribriform Carcinoma. Cancer Invest 2024:1-7. [PMID: 39058247 DOI: 10.1080/07357907.2024.2383930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Revised: 12/19/2023] [Accepted: 07/20/2024] [Indexed: 07/28/2024]
Abstract
Invasive cribriform carcinoma (ICC) is a type of malignant tumor with slow growth and good prognosis. The study was a single center retrospective study. The percentage of ICC among patients diagnosed with breast cancer was 0.3% (8/2454 patients). All patients tested positive for estrogen or progesterone receptors and 12.5% (1/8) patients tested positive for human epidermal growth factor receptor type2 (HER2). The present study suggests that the clinicopathological features of ICC are low-grade hormone receptor-positive luminal type with a good prognosis. However, some patients were HER2-positive and require careful follow-up.
Collapse
Affiliation(s)
- Ryusei Yoshino
- Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Hokkaido, Asahikawa-shi, Japan
| | - Masaki Nakatsubo
- Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Hokkaido, Asahikawa-shi, Japan
| | - Nanami Ujiie
- Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Hokkaido, Asahikawa-shi, Japan
| | - Akane Ito
- Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Hokkaido, Asahikawa-shi, Japan
| | - Nana Yoshida
- Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Hokkaido, Asahikawa-shi, Japan
| | - Masahiro Kitada
- Department of Thoracic Surgery and Breast Surgery, Asahikawa Medical University Hospital, Hokkaido, Asahikawa-shi, Japan
| |
Collapse
|
2
|
Kos Z, Nielsen TO, Laenkholm AV. Breast Cancer Histopathology in the Age of Molecular Oncology. Cold Spring Harb Perspect Med 2024; 14:a041647. [PMID: 38151327 PMCID: PMC11146312 DOI: 10.1101/cshperspect.a041647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2023]
Abstract
For more than a century, microscopic histology has been the cornerstone for cancer diagnosis, and breast carcinoma is no exception. In recent years, clinical biomarkers, gene expression profiles, and other molecular tests have shown increasing utility for identifying the key biological features that guide prognosis and treatment of breast cancer. Indeed, the most common histologic pattern-invasive ductal carcinoma of no special type-provides relatively little guidance to management beyond triggering grading, biomarker testing, and clinical staging. However, many less common histologic patterns can be recognized by trained pathologists, which in many cases can be linked to characteristic biomarker and gene expression patterns, underlying mutations, prognosis, and therapy. Herein we describe more than a dozen such histomorphologic subtypes (including lobular, metaplastic, salivary analog, and several good prognosis special types of breast cancer) in the context of their molecular and clinical features.
Collapse
Affiliation(s)
- Zuzana Kos
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada
- BC Cancer Vancouver Centre, Vancouver, British Columbia V5Z 4E6, Canada
| | - Torsten O Nielsen
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada
- Molecular and Advanced Pathology Core, Vancouver, British Columbia V6H 3Z6, Canada
| | - Anne-Vibeke Laenkholm
- Department of Surgical Pathology, Zealand University Hospital, 4000 Roskilde, Denmark
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark
| |
Collapse
|
3
|
Chen P, Ho Y, Chen C, Chiu C. Invasive cribriform carcinoma of the breast presenting as an erythematous papule on the nipple: A case report. Clin Case Rep 2024; 12:e9055. [PMID: 38840754 PMCID: PMC11150131 DOI: 10.1002/ccr3.9055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2024] [Revised: 05/20/2024] [Accepted: 05/27/2024] [Indexed: 06/07/2024] Open
Abstract
Invasive cribriform carcinoma (ICC) is a rare form of invasive breast carcinoma with good prognosis. To date, case reports considering skin manifestations of ICC are scarce. We herein report a case of pure ICC presenting as an erythematous papule on the nipple with mammary Paget's disease in the epidermis. We aim to bring awareness to skin manifestation of ICC.
Collapse
Affiliation(s)
- Po‐Yu Chen
- Department of Medical EducationTaichung Veterans General HospitalTaichungTaiwan
| | - Yu‐Hsuan Ho
- Department of DermatologyTaichung Veterans General HospitalTaichungTaiwan
| | - Chih‐Jung Chen
- Department of Pathology and Laboratory MedicineTaichung Veterans General HospitalTaichungTaiwan
| | - Chien‐Shan Chiu
- Department of DermatologyTaichung Veterans General HospitalTaichungTaiwan
| |
Collapse
|
4
|
Wen Y, Bai J, Zheng C, Liu J, Lin S, Han H, Xu C. A nomogram for predicting the risk of male breast cancer for overall survival. Front Oncol 2023; 13:1068187. [PMID: 37601680 PMCID: PMC10436472 DOI: 10.3389/fonc.2023.1068187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2022] [Accepted: 07/20/2023] [Indexed: 08/22/2023] Open
Abstract
Background Male breast cancer (MBC) is a rare disease, accounting for <1% of all male carcinomas. Lack of prospective data, the current therapy for MBC is based on retrospective analysis or information that is extrapolated from studies of female patients. We constructed a nomogram model for predicting the overall survival (OS) of MBC patients and verify its feasibility using data from China. Methods Constructed a predictive model using 1224 MBC patients from the Surveillance, Epidemiology and End Results (SEER) registry between 2010 and 2015. The performance of the model was externally validated between 2002 to 2021 using 44 MBC patients from the Fujian Medical University Union Hospital. The independent prognostic factors were selected by univariate and multivariate Cox regression analyses. The nomogram was constructed to predict individual survival outcomes for MBC patients. The discriminative power, calibration, and clinical effectiveness of the nomogram were evaluated by the receiver operating characteristic (ROC) curve, and the decision curve analysis (DCA). Results A total of 1224 male breast cancer patients were in the training cohort and 44 in the validation cohort. T status (p<0.001), age at diagnosis (p<0.001), histologic grade (p=0.008), M status (p<0.001), ER status (p=0.001), Her2 status (p=0.019), chemotherapy (p=0.015) were independently associated with OS. The diagnostic performance of this model was evaluated and validated using ROC curves on the training and validation datasets. In the training cohort, the nomogram-predicted AUC value was 0.786 for 3-year OS and 0.767 for 5-year OS. In the validation cohort, the nomogram-predicted AUC value was 0.893 for 3-year OS and 0.895 for 5-year OS. Decision curve analysis demonstrated that the nomogram was more benefit than the AJCC stage. Conclusions We developed a nomogram that predicts 3-year and 5-year survival in MBC patients. Validation using bootstrap sampling revealed optimal discrimination and calibration, suggesting that the nomogram may have clinical utility. The results remain reproducible in the validation cohort which included Chinese data. The model was superior to the AJCC stage system as shown in the decision curve analysis (DCA).
Collapse
Affiliation(s)
- Yahui Wen
- Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
| | - Junjie Bai
- Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Department of Urology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
| | - Caihong Zheng
- Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
| | - Jiameng Liu
- Department of Breast Surgery, Women and Children’s Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Shunguo Lin
- Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian, China
| | - Hui Han
- Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian, China
| | - Chunsen Xu
- Department of Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China
- Breast Cancer Institute, Fujian Medical University, Fuzhou, Fujian, China
| |
Collapse
|
5
|
Xia L, Chen X. Invasive cribriform carcinoma of the breast: A case report. Asian J Surg 2023; 46:1130-1131. [PMID: 35995718 DOI: 10.1016/j.asjsur.2022.08.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2022] [Accepted: 08/06/2022] [Indexed: 11/16/2022] Open
Affiliation(s)
- Liqin Xia
- Department of Pathology, Wuyi County First People's Hospital, Wuyi, Zhejiang, 321200, PR China.
| | - Xiao Chen
- Department of Ultrasound, Wuyi County First People's Hospital, Wuyi, Zhejiang, 321200, PR China
| |
Collapse
|
6
|
Tuan HX, Duc NM, Huy NA, Tri CM, Quyen HTD, Truc BT, Trung NT, Dieu AN, Dung PX. A rare case of breast invasive cribriform carcinoma. Radiol Case Rep 2023; 18:1049-1052. [PMID: 36684641 PMCID: PMC9849982 DOI: 10.1016/j.radcr.2022.12.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2022] [Revised: 12/06/2022] [Accepted: 12/10/2022] [Indexed: 01/09/2023] Open
Abstract
Although invasive ductal carcinoma accounts for 75% of all primary breast cancers diagnosed, there are other, more uncommon kinds, including invasive cribriform carcinoma (ICC). Invasive cribriform carcinoma has 2 subtypes: pure and mixed. Ultrasonography and magnetic resonance imaging are the best imaging methods for assessing the characteristics of breast ICC (MRI). Our goal in this article was to report a rare instance of breast ICC in a 38-year-old Vietnamese woman. During a clinical examination, a spherical mass in the left breast without ipsilateral axillary lymph nodes was seen. On ultrasonography, the lesion was classified as BI-RADS 4C. The lesion was with an apparent diffusion coefficient value of 0.46 × 10-3 mm2/s. Lesion showed a quick initial increase on dynamic T1-weighted imaging with contrast enhancement, followed by a wash-out in the delayed phase. The final histopathological findings confirmed the presence of ICC.
Collapse
Affiliation(s)
- Ho Xuan Tuan
- Department of Medical Imaging, University of Medical Technology and Pharmacy, Da Nang, Vietnam
| | - Nguyen Minh Duc
- Department of Radiology, Pham Ngoc Thach University of Medicine, 2 Duong Quang Trung Ward 12 District 10, Ho Chi Minh City, Vietnam,Department of Radiology, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam,Corresponding author.
| | - Nguyen Anh Huy
- Department of Radiology, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam
| | - Cao Minh Tri
- Department of Radiology, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam
| | - Huynh-Thi Do Quyen
- Department of Radiology, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam
| | - Bui Thanh Truc
- Department of Radiology, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam
| | - Nguyen Tin Trung
- Department of Radiology, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam
| | - Au Nguyet Dieu
- Department of Pathology, Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam,Department of Pathology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam
| | - Pham Xuan Dung
- Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam
| |
Collapse
|
7
|
Prognostic relevance of mixed histological subtypes in invasive breast carcinoma: a retrospective analysis. J Cancer Res Clin Oncol 2022:10.1007/s00432-022-04443-x. [DOI: 10.1007/s00432-022-04443-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2022] [Accepted: 10/19/2022] [Indexed: 11/06/2022]
Abstract
Abstract
Purpose
The prognostic and therapeutic power of special histological subtypes in breast cancer in pure form or in combination with other histological subtypes is still not established, and diagnostic guidelines are cautious regarding prognostic power based on the histological subtype alone. Therapy decisions are guided in most cases independently of the histological subtype and are directed by biomarkers and tumor stage. In this study, we analyzed a comprehensive large retrospective breast cancer cohort with a special focus on histological subtype (other than ductal non-special type or lobular carcinoma) and correlated pure or mixed histological forms with pathological tumor stage and overall disease-free survival.
Materials and methods
A total of 827 breast cancer cases with pure or mixed special histological types were retrospectively analyzed. Survival information was available in 645 of 827 cases.
Results
A total of 293 cases had pure forms, and 534 cases had mixed histological subtypes. The most common pure special types were mucinous (23.9%), micropapillary (21.2%), high-grade metaplastic (13%), male breast cancer (8.2%), cribriform (6.8%), metastases (6.1%), apocrine and papillary (each 5.46%), NST with medullary and clear cell pattern (up to 3.4%) and high-grade neuroendocrine carcinomas (2.7%). Mixed forms were most frequently encountered in NST carcinomas with micropapillary components (41.8%), followed by mucinous (9.93%) and cribriform (6.74%) mixed patterns. In univariate analysis, no pure form had prognostic relevance compared with any mixed form with the basic pure element. Pooling pure histological subtypes with tumor stage and age in a linear random-effects model, the cribriform subtype had the most favorable prognosis, while male breast cancer showed the poorest outcome (p < 0.001). All other frequent pure forms had intermediate prognostic power (p < 0.001).
Conclusion
Our results show that the analyzed special histological breast cancer subtypes (other than ductal and lobular carcinomas) do not carry prognostic information alone, either in pure form or in any combination with other subtypes. Prognostic groups including special subtypes, however, can strongly stratify breast cancer if tumor stage, age and biomarkers are included in the prognostic measurements.
Collapse
|
8
|
Demir S, Sezgin G, Sari AA, Kucukzeybek BB, Yigit S, Etit D, Yazici A, Kucukzeybek Y. Clinicopathological analysis of invasive cribriform carcinoma of the breast, with review of the literature. Ann Diagn Pathol 2021; 54:151794. [PMID: 34325338 DOI: 10.1016/j.anndiagpath.2021.151794] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2020] [Revised: 06/27/2021] [Accepted: 07/11/2021] [Indexed: 10/20/2022]
Abstract
Invasive cribriform carcinoma (ICC) is a rare type of a primary breast carcinoma. It is subdivided into two groups as pure and mixed types. There are limited studies comparing the pure and mixed ICC at present. We aim to investigate the clinicopathological, radiological, prognostic features, and survival outcomes of two types with reviewing the published literature. 16 pure ICC and 26 mixed ICC cases were evaluated. The population consisted of 41 female and 1 male patients. The only male patient was a pure ICC case. The median age was for pure and mixed type, 46.5 and 54 years, respectively. All ICCs were ER positive. All ICCs except one mixed ICC, were positive for PR. Only one mixed ICC was accepted HER2 positive (3+). Pure ICCs showed more favorable features than mixed ICCs such as lesser axillary lymph node involvement, lower grade, and proliferation index. Twenty-five patients had one of the following imaging methods; ultrasonography (US), mammography (MG), and magnetic resonance imaging (MRI). Irregular shape, hypoechogenicity, and spiculated margins were the most common US findings. Similarly, irregular shape+spiculated margin is the most common MG findings. The median follow-up time for pure and mixed ICC was 88 and 56.5 months, respectively. One mixed ICC case developed bone metastasis. One death occurred in each group. Reasons of death were unknown. The 5-year OS for both ICC groups was 100%. 10-year OS for pure and mixed ICCs was 100% and 90%, respectively. 5-year DFS was 100% for pure ICC, and 94% for mixed ICC.
Collapse
Affiliation(s)
- Sinem Demir
- Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Pathology, Turkey
| | - Gulten Sezgin
- Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Radiology, Turkey
| | - Aysegul Akder Sari
- Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Pathology, Turkey.
| | - Betul Bolat Kucukzeybek
- Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Pathology, Turkey
| | - Seyran Yigit
- Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Pathology, Turkey
| | - Demet Etit
- Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Pathology, Turkey
| | - Ayse Yazici
- Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Pathology, Turkey
| | - Yuksel Kucukzeybek
- Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Oncology, Turkey
| |
Collapse
|